Screener
Pacific Biosciences of California PACB Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
FAQ
- What is Pacific Biosciences of California's total equity?
- Pacific Biosciences of California (PACB) reported total equity of -$33.21M in Q2 2026.
- How has Pacific Biosciences of California's total equity changed year-over-year?
- Pacific Biosciences of California's total equity decreased by 154.0% year-over-year, from $61.49M to -$33.21M.
- What is the long-term trend for Pacific Biosciences of California's total equity?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's total equity has grown at a -56.3% compound annual growth rate (CAGR), from $335.49M to $5.35M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Pacific Biosciences of California's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude